Mesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1/2-Fas/FasL-caspase3 pathway regulation

Mesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1/2-Fas/FasL-caspase3 pathway regulation

Abstract Background Liver transplantation is the optimal treatment option for end-stage liver disease, but organ shortages dramatically restrict its application. Donation after cardiac death (DCD) is an alternative approach that may expand the donor pool, but it faces challenges such as graft dysfun...

Full description

Bibliographic Details
Main Authors: Yang Tian, Jingcheng Wang, Wei Wang, Yuan Ding, Zhongquan Sun, Qiyi Zhang, Yan Wang, Haiyang Xie, Sheng Yan, Shusen Zheng
Format: Article
Language:English
Published: BMC 2016-10-01
Series:Stem Cell Research & Therapy
Subjects:
Mesenchymal stem cells
Donation after cardiac death
Graft survival
Kupffer cells
Apoptosis
Online Access:http://link.springer.com/article/10.1186/s13287-016-0416-y

Internet

http://link.springer.com/article/10.1186/s13287-016-0416-y

Similar Items